James Shin's Stock Ratings

Deutsche Bank Analyst

James Shin is an analyst at Deutsche Bank. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/23/2024

Overall Average Return

40.0%

Smart Score

78.3%

Overall Average Return Percentile

91st

Number of Ratings

14
Buy NowGet Alert
07/23/2024BMYBuy Now
Bristol-Myers Squibb
$42.755.26%$53 → $45MaintainsHoldGet Alert
05/23/2024LEGNBuy Now
Legend Biotech
$58.053.36% → $60Initiates → BuyGet Alert
05/23/2024INCYBuy Now
Incyte
$65.19-15.63% → $55Initiates → HoldGet Alert
11/09/2023LLYBuy Now
Eli Lilly
$869.10-38.44% → $535Initiates → HoldGet Alert
11/09/2023GILDBuy Now
Gilead Sciences
$72.413.58% → $75Initiates → HoldGet Alert
11/09/2023BMYBuy Now
Bristol-Myers Squibb
$42.7528.65% → $55Initiates → HoldGet Alert
11/09/2023ABBVBuy Now
AbbVie
$173.61-13.6% → $150Initiates → HoldGet Alert
11/09/2023REGNBuy Now
Regeneron Pharmaceuticals
$1.07K-25.22% → $800Initiates → HoldGet Alert
11/09/2023MRKBuy Now
Merck & Co
$125.65-8.48% → $115Initiates → BuyGet Alert
11/09/2023AMGNBuy Now
Amgen
$336.11-28.59% → $240Initiates → HoldGet Alert
11/09/2023IMGNBuy Now
Immunogen
—— → $25Initiates → BuyGet Alert
11/09/2023AUTLBuy Now
Autolus Therapeutics
$4.30132.56% → $10Initiates → BuyGet Alert
11/09/2023STROBuy Now
Sutro Biopharma
$3.99200.75% → $12Initiates → BuyGet Alert
12/12/2022AFMDBuy Now
Affimed
$5.1136.99%$80 → $70MaintainsOverweightGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free